ACADIA Pharmaceuticals Inc Net Asset Quality Index
ACADIA Pharmaceuticals Inc net asset quality index. ACADIA Pharmaceuticals Inc (ACAD) has a Net Asset Quality Index of 75.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.74 Billion minus total liabilities of $436.29 Million yields net assets of $1.31 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See ACADIA Pharmaceuticals Inc (ACAD) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of ACADIA Pharmaceuticals Inc (2000–2025)
Net asset quality index of ACADIA Pharmaceuticals Inc from 2000 to 2025. This chart shows how ACADIA Pharmaceuticals Inc's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of June 2026, the index stands at 75.0%, representing net assets of $1.31 Billion against total assets of $1.74 Billion USD. Check ACADIA Pharmaceuticals Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
ACADIA Pharmaceuticals Inc Net Asset Quality Index by Year (2000–2025)
ACADIA Pharmaceuticals Inc net asset quality index by year from 2000 to 2025. The table below presents the year-by-year Net Asset Quality Index for ACADIA Pharmaceuticals Inc from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ACADIA Pharmaceuticals Inc (ACAD) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 78.5% | $1.23 Billion | $1.56 Billion | $336.81 Million | ▲ +16.8 pp |
| 2024 | 61.7% | $732.79 Million | $1.19 Billion | $454.96 Million | ▲ +4.0 pp |
| 2023 | 57.6% | $431.75 Million | $748.96 Million | $317.20 Million | ▼ -10.5 pp |
| 2022 | 68.1% | $400.41 Million | $587.81 Million | $187.40 Million | ▼ -9.1 pp |
| 2021 | 77.3% | $540.89 Million | $700.12 Million | $159.23 Million | ▼ -2.9 pp |
| 2020 | 80.1% | $627.01 Million | $782.62 Million | $155.61 Million | ▼ -9.2 pp |
| 2019 | 89.3% | $699.13 Million | $783.18 Million | $84.05 Million | ▲ +0.6 pp |
| 2018 | 88.7% | $479.08 Million | $540.20 Million | $61.12 Million | ▲ +1.5 pp |
| 2017 | 87.2% | $335.29 Million | $384.51 Million | $49.22 Million | ▼ -5.2 pp |
| 2016 | 92.4% | $518.41 Million | $561.15 Million | $42.74 Million | ▲ +2.4 pp |
| 2015 | 90.0% | $199.76 Million | $221.90 Million | $22.13 Million | ▼ -5.1 pp |
| 2014 | 95.1% | $309.49 Million | $325.46 Million | $15.97 Million | ▼ -1.2 pp |
| 2013 | 96.3% | $182.13 Million | $189.12 Million | $6.99 Million | ▲ +18.0 pp |
| 2012 | 78.3% | $84.98 Million | $108.59 Million | $23.61 Million | ▲ +5.5 pp |
| 2011 | 72.7% | $23.36 Million | $32.11 Million | $8.75 Million | ▼ -4.6 pp |
| 2010 | 77.3% | $29.69 Million | $38.39 Million | $8.71 Million | ▲ +52.9 pp |
| 2009 | 24.4% | $12.11 Million | $49.68 Million | $37.57 Million | ▼ -57.5 pp |
| 2008 | 81.9% | $52.99 Million | $64.68 Million | $11.69 Million | ▼ -2.7 pp |
| 2007 | 84.7% | $113.93 Million | $134.58 Million | $20.65 Million | ▲ +9.7 pp |
| 2006 | 75.0% | $67.16 Million | $89.54 Million | $22.39 Million | ▲ +12.0 pp |
| 2005 | 63.0% | $39.37 Million | $62.51 Million | $23.13 Million | ▼ -13.0 pp |
| 2004 | 76.0% | $30.68 Million | $40.37 Million | $9.68 Million | ▲ +242.2 pp |
| 2003 | -166.2% | $-52.67 Million | $31.69 Million | $84.36 Million | ▲ +84.0 pp |
| 2002 | -250.2% | $-40.09 Million | $16.02 Million | $56.11 Million | ▼ -331.5 pp |
| 2001 | 81.3% | $17.86 Million | $21.96 Million | $4.10 Million | ▲ +147.3 pp |
| 2000 | -66.0% | $-22.51 Million | $34.11 Million | $56.62 Million | — |